13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 2 managers

Reported value

$275.3K

Holders

2

+1 new · −0 exited

Holders’ est. mark

$22.2K

Price effect on 1 books still in the name

Largest holder

$260.1K

Henshaw Capital LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Henshaw Capital LLC8.92K$260.1K$22.2KAdded$22.2K
Leonteq Securities AG520$15.2KNew

Positions as of Q4 2021. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.